By employing multiparameter sorting, we identified in murine bone marrow (BM) a homogenous population of rare (B0.02% of BMMNC) Sca-1 þ lin À CD45 À cells that express by RQ-PCR and immunohistochemistry markers of pluripotent stem cells (PSC) such as SSEA-1, Oct-4, Nanog and Rex-1. The direct electronmicroscopical analysis revealed that these cells are small (B2-4 lm), posses large nuclei surrounded by a narrow rim of cytoplasm, and contain open-type chromatin (euchromatin) that is typical for embryonic stem cells. In vitro cultures these cells are able to differentiate into all three germ-layer lineages. The number of these cells is highest in BM from young (B1-monthold) mice and decreases with age. It is also significantly diminished in short living DBA/2J mice as compared to long living B6 animals. These cells in vitro respond strongly to SDF-1, HGF/SF and LIF and express CXCR4, c-met and LIF-R, respectively, and since they adhere to fibroblasts they may be coisolated with BM adherent cells. We hypothesize that this population of Sca-1 þ lin À CD45 À very small embryonic-like (VSEL) stem cells is deposited early during development in BM and could be a source of pluripotent stem cells for tissue/ organ regeneration.
Introduction
The concept that hematopoietic stem cells (HSC) isolated from relatively easily accessible sources such as bone marrow (BM), mobilized peripheral blood (mPB) or cord blood (CB) could be subsequently employed as precursors for other stem cells necessary for regeneration of various solid organs (e.g., heart, brain, liver or pancreas) created excitement in the scientific community. [1] [2] [3] [4] It had been postulated that HSC possess germlayer unrestricted plasticity and may transdifferentiate into stem cells from all non-hematopoietic lineages.
Unfortunately, following the first promising reports came some disappointment, when previously published data showing a robust contribution of 'HSC' to regeneration of different tissues were not reproduced by other investigators. [5] [6] [7] [8] [9] [10] In response to this, the scientific community became polarized in its view on stem cell plasticity. Several alternative explanations of previously reported data had been proposed. [11] [12] [13] The first concept that was rapidly accepted was explaining stem cell plasticity through the phenomenon of cell fusion. [14] [15] [16] Accordingly, data were presented that donor-derived HSC or monocytes may fuse with differentiated cells in recipient tissues which leads to the creation of daughter cells that have a double number of chromosomes in their nuclei and express cell surface and cytoplasmic markers that are derived from both parental cells. Another explanation of stem cell plasticity is based on a possibility of the appearance of epigenetic changes in cells exposed to external stimuli (e.g., organ damage, unphysiological culture conditions or stress). 17 Both cell fusion and epigenetic changes, however, are extremely rare and randomly occurring events that may not fully account for the previously published positive 'trans-dedifferentiation' data. Furthermore, fusion as a major contributor to the observed donor-derived chimerism was excluded in several recently published elegant studies. [18] [19] [20] [21] [22] [23] [24] In the deliberations concerning stem cell plasticity, the concept that BM may contain heterogeneous populations of stem cells was surprisingly not taken carefully enough into consideration. To support this notion several studies from our and other laboratories provided direct evidence that BM stem cells are heterogenous and perhaps pluripotent. 25, [26] [27] [28] [29] Accordingly, BM was found to contain endothelial-, 30, 31 bone-, [32] [33] [34] skeletal muscle-, 35 cardiac-, 36, 37 hepatic- [38] [39] [40] and neural-tissue committed stem cells 4, 41 and the potential list of versatile stem cells including mesenchymal stem cells (MSC), 42 multipotent adult progenitor cells (MAPC) 43 and as recently reported germ cells 28 is continuously expanding. However, these potential candidate cells had not been characterized well at the singlecell level.
Recently by employing multiparameter sorting, we identified in murine BM a homogenous population of rare (B0.02% of BMMNC) Sca-1 þ lin À CD45 À cells that express by RQ-PCR markers of non-hematopoietic tissue-committed stem cells (TCSC). 27, [44] [45] [46] More important, these rare cells were able in vitro cultures to grow neurospheres. 47 In the current study, we provide direct evidence that sorted from BM Sca-1 þ lin À CD45
À cells have the morphology and express several markers of undifferentiated embryonic-like stem cells and in vitro cultures may differentiate into cells from all three germ-layers. We hypothesize that this population of very small embryoniclike (VSEL) stem cells is deposited early in development in BM and that these cells could be employed for tissue/organ regeneration.
Bone marrow cells
Murine mononuclear cells (MNC) were isolated from BM flushed from the femurs of pathogen-free, 3-week-, 1-monthand 1-year-old female C57Bl6, DBA/2 J or 3-4 weeks old C57BL/6-Tg(ACTB-EGFP)1Osb/J mice (The Jackson Laboratory, Bar Harbor, ME, USA). Erythrocytes were removed by hypotonic solution (Lysing Buffer, BD Biosciences, San Jose, CA, USA).
Sort of bone marrow-derived cells
Lin À /Sca-1 þ /CD45 À and Lin À /Sca-1 þ /CD45 þ cells were isolated from a suspension of murine BMMNCs by multiparameter, live sterile cell sorting (FACSVantage SE; Becton Dickinson, Mountainview, CA, USA or MoFlo, Dako A/S, Fort Collins, CO, USA). Briefly, BMMNCs (100 Â 10 6 cells/ml) were resuspended in cell-sort medium (CSM), containing 1 Â Hank's Balanced Salt Solution without phenol red (GIBCO, Grand Island, NY, USA), 2% heat-inactivated fetal calf serum (FCS; GIBCO), 10 mM HEPES buffer (GIBCO), and 30 U/ml of Gentamicin (GIBCO). The following mAbs were employed to stain these cells: biotinconjugated rat anti-mouse Ly-6A/E (Sca-1) (clone E13-161.7), streptavidin-PE-Cy5 conjugate, anti-CD45-APC-Cy7 (clone 30-F11), anti-CD45R/B220-PE (clone RA3-6B2), anti-Gr-1-PE (clone RB6-8C5), anti-TCRab PE (clone H57-597), anti-TCRgz PE (clone GL3), anti-CD11b PE (clone M1/70) and anti-Ter-119 PE (clone TER-119). All mAbs were added at saturating concentrations and the cells were incubated for 30 min on ice and washed twice, then resuspended for sort in CSM at a concentration of 5 Â 10 6 cells/ml.
Side population cell isolation
Side population (SP) cells were isolated from the BM according to the published method. 48 Briefly, BMMNC were resuspended at 10 6 cells/ml in prewarmed DMEM/2% FBS and preincubated at 371C for 30 min. The cells were then labeled with 5 mg/ml Hoechst 33342 (Sigma Aldrich, St Louis, MO, USA) in DMEM/ 2% FBS and incubated at 371C for 90 min. After staining, the cells were pelleted, resuspended in ice-cold cell-sort medium, and then maintained on ice until their sorting. Analysis and sorting were performed using a FACSVantage (Becton Dickinson, Mountainview, CA, USA). The Hoechst dye was excited at 350 nm and its fluorescence emission was collected with a 424/44 band pass (BP) filter (Hoechst blue) and a 675/20 BP filter (Hoechst red). All the parameters were collected using linear amplification in list mode and displayed in a Hoechst blue versus Hoechst red dotplot to visualize the SP. Then, Lin
þ cells were isolated from a suspension of SP using biotin-conjugated rat anti-mouse Ly-6A/E (Sca-1) (clone E13-161.7), streptavidin-PE-Cy5 conjugate, anti-CD45-APC-Cy7 (clone 30-F11), anti-CD45R/B220-PE (clone RA3-6B2), anti-Gr-1-PE (clone RB6-8C5), anti-TCRab PE (clone H57-597), anti-TCRgz PE (clone GL3), anti-CD11b PE (clone M1/70) and anti-Ter-119 PE (clone TER-119) antibodies.
Transmission electron microscopy analysis
For transmission electron microscopy (TEM), the Lin
þ cells were fixed in 3% glutaraldehyde in 0.1 M cacodylate buffer pH 7.4 for 10 h at 41C, post-fixed in osmium tetride and dehydrated. Fixed cells were subsequently embedded in LX112 and sectioned at 800 Å , stained with uranyl acetate and lead citrate and viewed on a Philips CM10 electron microscope operating at 60 kV.
Differentiation assays
For coculture assays in order to prepare a supportive cell-layer 2 Â 10 6 of wild-type BMMNC were plated in 23 mm Flurorodishes (World Precision Instruments Inc, Sarasota, FL, USA). At 24 h, the latter purified by FACS GFP þ cells were added as described below.
Neuronal differentiation. To generate neuronal derivatives (neurons, oligodendrocytes, glial cells), 5 Â 10
þ were cultured along with unpurified GFP À BM cells in NeuroCult Basal Medium (Stem Cell Technologies, Vancouver, BC, Canada) supplemented with 10 ng/ml rhEGF, 20 ng/ml FGF-2 and 20 ng/ml NGF (all growth factors from R&D Systems, Minneapolis, MN, USA). Growth factors were added every 24 h and medium was replaced every 2-3 days. The cultures were examined after 21-25 days.
were cultured along with unpurified GFP À BM cells in DMEM/F12 medium with 4 mM Lglutamine, 4.5 g/l glucose, 1% heat-inactivated FBS and 50 ng/ ml of recombinant human Activin A (R&D Systems, Minneapolis, MN, USA). After 48 h, the medium was exchanged and differentiation was carried out in DMEM/F12 medium with 4 mM L-glutamine, 4.5 g/l glucose, 5% heat-inactivated FBS in the presence of N2 supplement-A, B27 supplement and 10 mM Nicotinamide (purchased from Stem Cell Technologies, Vancouver, BC, Canada). Medium was changed every second day. Islet-like clusters appeared after 17-21 days of culture.
) with unpurified GFP À BM cells were plated in DMEM with 4 mM L-glutamine, 4.5 g/l glucose, 10% heat-inactivated FBS and 10 ng/ml bFGF, 10 ng/ml VEGF, 10 ng/ml TGFb1 (all growth factors from R&D Systems, Minneapolis, MN, USA). Growth factors were added every 24 h and medium was replaced every 2-3 days. Cultures were examined after 21-28 days of differentiation.
Reverse transcriptase-polymerase chain reaction
Total RNA was isolated using RNeasy Mini Kit (Quiagen Inc., Valencia, CA, USA). mRNA (10 ng) was reverse-transcribed with One
Step reverse transcriptase-polymerase chain reaction (RT-PCR) (Quiagen Inc., Valencia, CA, USA) according to the instructions of the manufacturer. The resulting cDNA fragments were amplified using HotStarTaq DNA Polymerase (Quiagen Inc., Valencia, CA, USA). Primer sequences for CXCR4 were forward primer: 5 0 -GAC GGA CAA GTA CCG GCT GC-3 0 and reverse primer: 5 0 -GAC AGC TTA GAG ATG ATG AT-3 0 , for Met receptor were forward primer: 5 0 -CGC GTC GAC TTA TTC ATG G-3 0 and reverse primer: 5 0 -CAC ACA TTG ATT GTG GCA CC -3 0 , for LIF-R were forward primer: 5 0 -GAG CAT CCT TTG CTA TCG GAA GC-3 0 and reverse primer: 5 0 -CGT TAT TTC CTC CTC GAT GAT GG-3 0 . Correct size of PCR products was confirmed by separation on agarose gel.
Real time reverse transcriptase-polymerase chain reaction
For analysis of Oct4, Nanog, Rex1, Dppa3, Rif1, Myf5, MyoD, Myogenin, GFAP, nestin, b III tubulin, Olig1, Olig2, a -fetoprotein, CK19, Nsx2.5/Csx, GATA-4, Tnn I, Mybpc3, Actn2, Actn3, VE-cadherin, DCT, TYR, TRP, Nkx 2-3, Tcf4, Krt To avoid the possibility of amplifying contaminating DNA (i) all of the primers for real-time RT-PCR were designed containing a DNA intron sequence for specific cDNA amplification, (ii) reactions were performed with appropriate negative controls (template-free controls), (iii) a uniform amplification of the products was rechecked by analyzing the melting curves of the amplified products (dissociation graphs), (iv) the melting temperature (T m ) was 57-601C, the product T m was at least 101C higher than primer T m, and finally and (v) gel electrophoresis was performed to confirm the correct size of the amplification and the absence of unspecific bands.
Fluorescent staining of the sorted cells
The expression of each antigen was examined in cells from four independent sorts. The Lin À /Sca-1 þ /CD45 À cells were fixed in 3.5% paraformaldehyde for 20 min, permeabilized by 0.1% Triton X100, washed in PBS, preblocked with 2% BSA and subsequently stained with antibodies to CXCR4 (1:100, rabbit polyclonal IgG; Santa Cruz Biotechnology, Santa Cruz, CA, USA), Met (1:100, rabbit polyclonal IgG; Santa Cruz Biotechnology, Santa Cruz, CA, USA), LIF Receptor gp190 Table 1 Sequences of primers employed for real time RT-PCR 
Long-term repopulating assay
For transplantation experiments, C57BL/6 (Ly 5.2) mice were irradiated with a lethal dose of g-irradiation (900 cGy). After 24 h, the mice were transplanted (by tail vein injection) with with 2 Â 10
þ from C57BL/6 (Ly5.1) mice along with 10 6 of BMMNC isolated from C57BL/6 (Ly5.2). Transplanted mice were bled at various intervals from the retro-orbital plexus to obtain samples for Ly5-phenotyping. Final analysis of donor-derived chimerism was evaluated 8 months after transplantation.
Chimerism assay
Samples of PBMNC and BMMNC were analyzed on a FACSVantage (Becton Dickinson, Mountainview, CA, USA).
Cells were stained with FITC-conjugated anti-Ly5.2 (clone 104) and PE-conjugated anti-Ly5.1 (clone A20). The percentage of donor engraftment was calculated from two separate measurements (Ly5.1-positive and Ly5.2-negative) after subtraction of background.
In vitro migration assay to 'matrigel drop'
To investigate cell migration, briefly the SDF-1 at the concentration of 200 ng/ml or HGF/SF (10 ng/ml) or LIF (100 ng/ml) were dissolved in a Growth Factor Reduced Matrigel Matrix (BD Bioscience, Bedford, MA, USA) at 41C. As a control the Growth Factor Reduced Matrigel Matrix without chemoattractant was used. 
Statistical analysis
Arithmetic means and s.d. of our FACS data were calculated on a Macintosh computer PowerBase 180, using Instat 1.14 (GraphPad, San Diego, CA, USA) software. Data were analyzed using the Student's t-test for unpaired samples or ANOVA for multiple comparisons. Statistical significance was defined as Po0.05. 27 and that these latter cells are highly enriched in mRNA for markers of early TCSC. 45, 46 In the current study, we have evaluated the morphology of these rare cells by employing transmission electron microscopy (TEM). We noticed (Figure 1) (Figure 1  panel a) . Thus, we provide for the first time morphological evidence for the presence of VSEL stem cells in adult BM.
Bone marrow-derived Sca-1 þ lin À CD45 À very small embryonic-like cells express several pluripotent stem cell markers
In our previous studies, we reported that Sca-1 þ lin À CD45
À cells express mRNA typical for some TCSC. 27, 44, 46 This was confirmed in this study by evaluating an extensively expanded panel of genes for several markers of TCSC for neural tissue, skeletal and heart muscle, liver, pancreas, epidermis, melanocytes and intestinal epithelium (Table 2) . Interestingly, we also found that VSEL cells express mRNA for pluripotent stem cells (PSC) (Oct-4, Nanog, Rex1, Dppa3) and are enriched in mRNA for telomerase protein Rif1 (Table 3) .
More importantly we provide an evidence that purified Sca-1 þ lin À CD45 À VSEL cells express several embryonic stem cell markers (SSEA-1, Oct-4 and Nanog) at the protein level (Figure 2) . Accordingly, SSEA-1, Oct-4 and Nanog were detectable on 5777, 4376 and 2874% Sca-1 þ lin À CD45 À cells, respectively. This is the first demonstration that PSC proteins are expressed in a freshly isolated defined population of cells from the BM.
In parallel experiments, we compared by real time RT-PCR expression of selected markers between VSEL cells and an established pluripotent murine embryonic stem cell line ES-D3. We found that VSEL cells express mRNA for Oct-4, Nanog, Rex-1 and Dppa3 at similar levels as ES-D3 cells (Table 3) .
Bone marrow-derived Sca-1 þ lin À CD45 À VSEL cells differentiate in vitro cultures into cardiomyocytes, neural and pancreatic cells
To provide evidence that VSEL cells described here by us not only express markers and have a similar morphology of pluripotent embryonic stem cells, we attempted to differentiate these cells in vitro into cells from all three germ layers. However, highly purified VSEL cells if cultured alone are able to survive in vitro for several weeks (not shown) they do not proliferate and differentiate. In order to achieve tissue differentiation of these cells, we had to coculture them in differentiating media together with freshly isolated marrow cells. In order to demonstrate tissue-specific contribution of Sca-1 þ lin À CD45 À VSEL cells in cocultures, VSEL cells were isolated Figure 3 shows that VSEL cells are able to differentiate into cardiomyocytes (mesoderm), neurons, astrocytes and oligodendrocytes (ectoderm) and pancreas (endoderm). Accordingly, we observed that B5% of VSEL cells initiated neural-, B2% cardiomyocytic-and B3% pancreatic cell cultures. The analysis of DNA content in GFP þ cells isolated from the cocultures excluded the contribution of cell fusion to this effect. Furthermore, the corresponding increase in expression of tissue-specific proteins during cell differentiation in these cultures was confirmed by real time RT-PCR. In contrast, VSEL cells the hematopoietic Sca-1 þ lin À CD45 þ did not differentiate into non-hematopoietic lineages. Thus, these experiments revealed the pluripotency of VSEL cells and their ability to differentiate into cells from all germ layers.
cells express CXCR4, c-met and LIF-R
In our previous studies, we have demonstrated that BM-derived cells that express markers of TCSC could be isolated from a suspension of BMMNC by employing chemotaxis to stromal derived factor-1 (SDF-1), hepatocyte growth factor/scatter factor (HGF/SF) or leukemia inhibitory factor (LIF) gradients. 26 In this study, we phenotyped the corresponding population of Sca-1 þ lin À CD45 À VSEL cells purified by FACS for expression of the corresponding receptors (CXCR4, c-met and LIF-R). Figure 4 panel a shows that Sca-1 þ lin À CD45 À VSEL cells sorted by FACS express mRNA for all of these receptors. More importantly as shown in Figure 4 panel b, expression of these receptors was also confirmed by immunostainning. These receptors were present on 8276% (CXCR4), 6178% (c-met) and 4375% (LIF-R) purified Sca-1 þ lin À CD45 À VSEL cells. Furthermore, in direct chemotactic studies, we noticed that these highly purified cells respond robustly to SDF-1 (Figure 4 panel c 27 Hereby, employing FACS analysis of BMMNC derived from 1-month-and 1-year-old mice (Figure 5a ), we provide evidence that the number of Sca-1 þ lin À CD45 À VSEL cells is reduced by B6-10 times in BM from older animals (Figure 5a lower panel) . Furthermore our FACS analysis corresponded with a significant decrease of mRNA expression for PSC and TCSC markers in BMMNC isolated from older animals as evaluated by RQ-PCR (Figure 5b ). (Figure 7 panel a) . For comparison, we also isolated from the same marrow samples Sca-1 þ lin À CD45 À cells (Figure 5a ). Subsequently, we sorted from SP BMMNC both Sca-
All of these populations of cells were compared along with unpurified BMMNC for expression of mRNA for pluripotent VSEL cells (Figure 7 panel b) .
We noticed that SP is highly enriched in mRNA for markers of VSEL cells (Figure 7 panel b) 
þ BMMNCs were cocultured with unpurified GFP negative BMMNC in cardiac (a and b), neural (c-e) and pancreatic, (f) differentiation media. Expression of (a) a-sarcomeric actinin, (b) troponin I, (c) O4, (d) nestin, (e) b-III tubulin and (f) c-peptide. All proteins -red fluorescence. Nuclei identified by DAPI. All images were taken under a Plan Fluor 20XA/0.50 objective (Nikon, Japan). Representative data from three independent experiments are shown. Negative staining controls and negative data for GFP
Changes in the expression of mRNA for markers of (a) early (Nkx2.5/Csx and GATA-4) and late (Troponin I, Mybpc3, a-sarcomeric actinin 2 and 3) myocardium, (b) early (FOXA2 and SOX17) and late (glucagon, Insulin I, Insulin II, albumin 1, lapp and Amy2) pancreatic cells and (c) early (GFAP and Olig1) and late (nestin, bIII tubulin, Olig2) neural cells. The data are pooled together from three independent experiments. *Po0.001.
Embryonic-like stem cells in adult bone marrow M Kucia et al looked if these cells are able to grow in vitro hematopoietic colonies, but no clonogeneic activity of these cells was detected. Next, Sca-1
þ cells did not radioprotect lethally irradiated mice or form CFU-S colonies in lethally irradiated syngeneic recipients. 46, 47 To address if these cells may be enriched for some long-term hematopoietic repopulating stem cells, we evaluated in the current study the contribution of these cells to long-term repopulation of the hematopoietic system after transplantation to lethally irradiated mice by emloying donor/recipient animals congeneic at the Ly. 
þ cells into lethally irradiated syngeneic recipients (not shown).
Discussion
Contribution of BM-derived cells to organ regeneration was explained by the phenomenon of trans-dedifferentiation of HSC. However, we recently demonstrated that BM contains a population of rare Sca-1 þ lin À CD45 À cells that express by RQ-PCR and immunhistochemistry several markers of non-HSC and are able to differentiate in vitro cultures into ectoderm-derived neural cells. 47 We called these cells TCSC and postulated that they may circulate during organogenesis and rapid body growth/ expansion. Since they respond to an SDF-1 gradient, the SDF-1-CXCR4 axis alone or in combination with other chemoattractants plays a crucial role in accumulation of these cells in young BM. 44 Here, we report for the first time that these highly purified BMderived Sca-1 þ lin À CD45 À cells (B0.02% of BMMNC) express both at the mRNA and protein level several embryonic stem cell The open type of chromatin in these cells correlates with the presence of mRNA not only for embryonic stem cells but also mRNA for several TCSC -for example, skeletal muscle, heart muscle, neural, liver, intestinal epithelium, skin epidermis, melanocytes and endocrine pancreas. Furthermore, our cells described here express pluripotent stem cell markers at similar levels as established murine embryonic stem cell line ES-D3 (Table 3) .
Thus this is the first study that has identified at the morphological level a population of embryonic-like cells in adult BM. However, since some of these cells as reported previously by us express early developmental markers for neural, cardiac or skeletal muscles at the protein level 26, 46, 47 suggests that despite their similar homogenous morphology these cells show some degree of tissue commitment and are heterogenous. Nevertheless, these cells are enriched in a pluripotent stem cell population, which as we have demonstrated here gave rise in cocultures with BM cells to cells from all germ-cell layers.
Based on this observation, we propose to change the name of these cells from TCSC as they were described in our initial publication 26 to VSEL cells. We envision that VSEL cells find in BM a permissive environment to survive, and what we believe may play an underappreciated role as a reserve pool of circulating stem cells for organ/tissue regeneration during postnatal life. It is well documented that expression of several potential chemoattractants of stem cells for example, SDF-1, 52 as well as HGF/SF and LIF is upregulated in damaged organs and hypoxia regulated/induced transcription factor (HIF-1) plays an important role in their expression. 53, 54 To support this notion, promoters of SDF-1, HGF/SF and LIF, contain several functional HIF-1 binding sites. Thus SDF-1-CXCR4, HGF/SF-c-met and LIF-LIF-R axes may direct trafficking of stem cells. To support this notion, we demonstrated direct evidence that highly purified Sca-1 þ lin À CD45 À cells express CXCR4, c-met and LIF-R, at the protein level and respond robustly by chemotaxis to SDF-1, HGF/SF and LIF gradients, respectively. This observation is in agreement with the fact that murine embryonic stem cells also express functional CXCR4, c-met and LIF-R on their surface, and SDF-1, HGF/SF and LIF affect the motility of these cells. [55] [56] [57] One could also expect that if a population of Sca-1 þ lin À CD45 À BMMNC is enriched in embryonic-like PSC, these VSEL cells should be also able to differentiate along the hematopoietic lineage. In contrast, these cells in our hands neither protected lethally irradiated mice nor contributed to long-term hematopoiesis after transplantation into lethally irradiated recipients. However, it is also likely that in our standard assays the potential pluripotency of Sca-1 þ lin À CD45
À BMMNC was not detected and the final answer on their hematopoietic potential will be obtained after injection of VSEL cells into a developing blastocyste. The number of identified by us embryonic-like stem cells is higher in BM in young animals, and their number decreases with age. Furthermore, Sca-1 þ lin À CD45 À cells are barely detectable in 1-year-old mice, which corresponds to a 50-year-old human. This age-dependent content of VSEL cells in BM may explain why regeneration processes are more efficient in younger individuals. We also noticed differences in the content of Sca-1 þ lin À CD45 À cells among BMMNC between long-and shortliving mouse strains. Our preliminary data show that the concentration of these cells in much higher in BM of long living (e.g., C57Bl6) as compared to relatively short-living (DBA/ 2 J) mice. Thus, it would be interesting to identify genes that are responsible for tissue distribution/expansion of these cells and we can expect that they could be involved in controlling the life span of mammals.
Finally, Sca-1 þ lin À CD45 À VSEL cells are highly mobile and respond to an SDF-1 gradient and adhere to BM-derived fibroblasts. 27 Time-lapse studies revealed that these cells attach rapidly to, migrate beneath and/or undergo emperipolesis in these cells. 27 Interaction of VSEL cells with BM-derived fibroblasts was efficiently inhibited after their preincubation with CXCR4 antagonist, T140 (unpublished). Since fibroblasts secrete SDF-1 and other chemottractants they may create a homing environment for these cells. Their robust interaction with BM-derived fibroblasts has an important implicationsuggesting that isolated BM stromal cells may be from the beginning 'contaminated' by VSEL cells. Thus, Sca-1 þ lin À CD45 À cells and not fibroblasts themselves could account for 'germ layer trans-dedifferentiation' observed for example in multipotential adult progenitor cells (MAPC), 58 unrestricted somatic stem cells (USSCs) 59 or marrow isolated adult multilineage inducible cells (MIAMI) 60 cell cultures. Based on this assumption, it is very likely that we are calling similar/ overlapping populations of non-hematopoietic CD45
À stem cells residing in BM by different names. Furthermore, the fact that Sca-1 þ lin À CD45 À VSEL cells are very small should be taken in consideration, especially in protocols based on gradient or velocity centrifugation employed to isolate stem cells from BM, mPB and CB. We postulate that it is very likely that the majority of VSEL cells because of their very small size could be lost during those isolation procedures. There are several questions to be answered in the future. First, it is likely that similar embryonic-like cells are also present in other tissues/organs. A population of poorly identified 'spore like' stem cells described in the past 61 could correspond to cells we identified in this study. Second, we cannot exclude the possibility that these cells, while residing/being 'trapped' in the BM, are not fully functional or remain 'locked' in a dormant state and need the appropriate activation signals by unidentified factors. Finally, in some cases these cells could be attracted to inflammatory areas, and if not properly incorporated into the damaged tissue may transform and initiate tumor grow. Such a possibility was suggested in recently published reports. 
Embryonic-like stem cells in adult bone marrow M Kucia et al
Mankind is searching for a key to longevity and there is no doubt that stem cells could be an important answer to this problem. Thus, there is a need for a reliable source of stem cells and VSEL cells could potentially provide a real therapeutic alternative for embryonic stem (ES) cells and therapeutic cloning. Therefore, in the time of ethical debates on the application of ES cells in therapy, the 'pluripotent/embryonic potential' of VSEL cells isolated from adult tissues should be tested in experimental models in vivo. The near future will answer if these rare cells are merely some developmental remnants in adult BM or if they could be efficiently employed in the clinic. To support this last notion, recently we observed that B7% of purified VSEL cells are able to form spheres that resemble embryoid bodies if plated over C2C12 murine sarcoma cell feeder layer. Cells from these embryoid like bodies are similarly as VSEL cells CXCR4
þ SSEA-1 þ Oct-4 þ and after replating over C2C12 cells may again (up to five to seven passages) grow new embryoid like bodies or if plated into cultures promoting tissue differentiation expand into cells from all three germ-cell layers (manuscript in preparation). This strongly suggests that it is possible to expand VSEL cells in quantities that will allow their further potential application for regeneration and this currently being tested in animal models.
